Patent US4342828A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4342828A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells

Assignee: Morinaga Milk Industry Co Ltd
•
Filing: 1980-07-15
•
Granted: 1982-08-03
•
Expires: 2000-07-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A colony stimulating factor effective in treating human granulocytopenia is produced by cultivating monocytes and macrophages isolated from the human peripheral blood in a synthetic medium for tissue culture containing a glycoprotein isolated from human urine and capable of stimulating the formation of human granulocytes or mouse macrophages and granulocytes.

Inventors

  • 👤 Fumimaro Takaku
  • 👤 Katsuhiro Ogasa
  • 👤 Morio Kuboyama
  • 👤 Nobuya Yanai
  • 👤 Muneo Yamada
  • 👤 Yoshiteru Watanabe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:35
CPC Classifications
C; C12; C12N; C12N1/00; C12N1/38; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/53; C07K14/535; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 94 words
A method for producing a substance capable of stimulating the proliferation and differentiation of human granulopoietic stem cells, which comprises cultivating monocytes and macrophages, which have been separated from the human peripheral blood, in a synthetic medium for tissue culture containing a glycoprotein separated from the human urine and capable of stimulating human or mouse bone marrow cells to form human granulocytes or mouse macrophages and granulocytes, thereby producing a substance capable of stimulating the proliferation and differentiation of human granulopoietic stem cells in the medium, and recovering the active substance from the medium.
Claim 2
Independent Claim 94 words
A method for producing a substance capable of stimulating the proliferation and differentiation of human granulopoietic stem cells, which comprises cultivating monocytes and macrophages, which have been separated from the human peripheral blood, in a synthetic medium for tissue culture containing a glycoprotein separated from the human urine and capable of stimulating human or mouse bone marrow cells to form human granulocytes or mouse macrophages and granulocytes, thereby producing a substance capable of stimulating the proliferation and differentiation of human granulopoietic stem cells in the medium, and recovering the active substance from the medium.
Claim 3
Dependent Claim 23 words
A method according to claim 1, wherein the glycoprotein is a glycoprotein capable of stimulating human bone marrow cells to form human granulocytes.
Claim 4
Dependent Claim 25 words
A method according to claim 1, wherein the glycoprotein is a glycoprotein capable of stimulating human bone marrow cells to form mouse macrophages and granulocytes.
Claim 5
Dependent Claim 17 words
A method according to claim 1, wherein the cultivation is carried out in the presence of serum.
Claim 6
Dependent Claim 16 words
A method according to claim 4, wherein the serum present in the medium is human serum.
Claim 7
Dependent Claim 23 words
A method according to claim 5, wherein the amount of the serum is at least 5% based on the volume of the medium.
Claim 8
Dependent Claim 23 words
A method according to claim 2, wherein the glycoprotein content of the medium is at least 0.1 μg per ml of the medium.
Claim 9
Dependent Claim 23 words
A method according to claim 3, wherein the glycoprotein content of the medium is at least 500 units per ml of the medium.
Claim 10
Dependent Claim 34 words
A method for producing a substance capable of stimulating the proliferation and differentiation of human granulopoietic stem cells according to claim 1, wherein the glycoprotein is a partially purified material accompanied with urinary proteins.
Claim 11
Dependent Claim 29 words
A method according to claim 1, wherein the number of cells of monocytes and macrophages inoculated into the medium is at least 10 5 per ml of the medium.

References Cited (Backward Citations)

US4135975A Cited
US4275056A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-08-02 1986-02-01 1986-08-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-08-02 1990-02-01 1990-08-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-08-02 1994-02-01 1994-08-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag